Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia

Lili Wang(Shanghai Jiao Tong University), Catherine J. Wu(Dana-Farber Cancer Institute), Stacey M. Fernandes(Dana-Farber Cancer Institute), Laura Z. Rassenti(University of California San Diego), Jennifer R. Brown(Dana-Farber Cancer Institute), Joshua Z. Levin(Broad Institute), Rutendo Gambe(Dana-Farber Cancer Institute), Jon C. Aster(Brigham and Women's Hospital), David S. DeLuca(Broad Institute), Jean Fan(Johns Hopkins University), Peter V. Kharchenko(Fleet Science Center), Thomas J. Kipps(University of California San Diego), Robin Reed(Harvard University), Donald B. Bloch(Harvard University), Kevin F. Chau(University of Wisconsin–Madison), Silvia Buonamici(New York University), Peter G. Smith(Kenya Medical Research Institute), Kenneth J. Livak(Broad Institute), Matthew Meyerson(Broad Institute), Carrie Cibulskis, Samuel S. Freeman(Broad Institute), Shanye Yin(Albert Einstein College of Medicine), Shuqiang Li(Anhui Normal University), Sarah Hergert(Dana-Farber Cancer Institute), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Emanuela M. Ghia(University of California San Diego), Dylan Kotliar(Broad Institute), Dan A. Landau(Cornell University), Angela N. Brooks(University of California, Santa Cruz), Youzhong Wan(Jilin University), Wandi Zhang(Dana-Farber Cancer Institute), Gad Getz(Broad Institute), Michael Seiler(Rutgers, The State University of New Jersey), Donna Neuberg(Otsuka (Japan))
Cancer Cell
November 1, 2016
Cited by 216


Related Papers